Randox takes 6.1% stake in Proaxsis Ltd, diagnostic assays firm
Published
Randox Laboratories Limited entered Proaxsis Ltd’s register with 209,511 preference shares. The new corporate holding was absent from the earlier register, making this a genuine new entry. The filing also records a substantial increase for MNL Nominees Limited, with the statement filed on 26 August 2026 for changes between 12 August 2025 and 12 August 2026.
Shareholder data
Source: Companies House confirmation statement (CS01) — period to , filed .
Changes in this confirmation statement
| Type | Shareholder | Shares | Change | Share classes |
|---|---|---|---|---|
| New shareholder | RANDOX LABORATORIES LIMITED | 209,511 | — | PREFERENCE 209,511 |
| Increased | MNL NOMINEES LIMITED | 1,880,885 | +154451% | PREFERENCE 1,808,668 ORDINARY 71,000 DEFERRED 1,217 |
| Increased | NETSCIENTIFIC UK LIMITED | 1,264,823 | +10000% | ORDINARY 1,100,000 PREFERENCE 152,300 DEFERRED 12,523 |
| Increased | NORTHERN IRELAND SCIENCE PARK PROPERTY LIMITED | 34,744 | +10000% | PREFERENCE 34,400 DEFERRED 344 |
Current shareholders (4)
| Shareholder | Total shares | Share classes |
|---|---|---|
| MNL NOMINEES LIMITED | 1,880,885 | ORDINARY 71,000 PREFERENCE 1,808,668 DEFERRED 1,217 |
| NETSCIENTIFIC UK LIMITED | 1,264,823 | ORDINARY 1,100,000 PREFERENCE 152,300 DEFERRED 12,523 |
| RANDOX LABORATORIES LIMITED | 209,511 | PREFERENCE 209,511 |
| NORTHERN IRELAND SCIENCE PARK PROPERTY LIMITED | 34,744 | PREFERENCE 34,400 DEFERRED 344 |
Contact the editorial team at editorial@fundingspotter.com